Startseite Naturwissenschaften Crystal structure of 1,3-dimethyl-5,5-dibenzylbarbituric acid, C20H20N2O3
Artikel Open Access

Crystal structure of 1,3-dimethyl-5,5-dibenzylbarbituric acid, C20H20N2O3

  • Ya-Nan Wei , Chuan-Bi Li EMAIL logo , Xue Li und Han-Yang Sun
Veröffentlicht/Copyright: 29. September 2017

Abstract

C20H20N2O3, orthorhombic, Pbca (no. 61), a = 9.1300(18) Å, b = 16.170(3) Å, c = 24.000(5) Å, V = 3543.2(12) Å3, Z = 8, Rgt(F) = 0.1274, wRref(F2) = 0.1434, T = 293 K.

CCDC no.:: 1522244

A part of the title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Block, colourless
Size:0.32 × 0.30 × 0.20 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.09 mm−1
Diffractometer, scan mode:Bruker SMART, φ and ω-scans
2θmax, completeness:26.1°, >99%
N(hkl)measured, N(hkl)unique, Rint:18209, 3512, 0.029
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2556
N(param)refined:226
Programs:Bruker programs [1], SHELX [2]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.7276(2)−0.10645(12)0.31703(8)0.0533(5)
C20.60565(19)−0.06394(10)0.40278(7)0.0446(4)
C30.69893(17)0.01292(10)0.40530(6)0.0397(4)
C40.79089(17)0.02945(10)0.35407(7)0.0421(4)
C50.5486(3)−0.19739(14)0.36065(11)0.0867(8)
H5A0.5755−0.22960.32860.130*
H5B0.4453−0.18640.35970.130*
H5C0.5722−0.22750.39390.130*
C60.9049(3)−0.02081(16)0.26821(9)0.0808(7)
H6A0.9006−0.06800.24400.121*
H6B1.0023−0.01530.28280.121*
H6C0.87970.02810.24760.121*
C70.60354(19)0.08915(10)0.41894(7)0.0461(4)
H7A0.55190.07820.45350.055*
H7B0.66840.13560.42560.055*
C80.49232(18)0.11501(10)0.37582(7)0.0432(4)
C90.3487(2)0.08880(12)0.37873(8)0.0561(5)
H90.32180.05010.40550.067*
C100.2444(2)0.11927(15)0.34250(10)0.0716(6)
H100.14790.10130.34520.086*
C110.2826(3)0.17595(15)0.30245(9)0.0712(6)
H110.21230.19670.27810.085*
C120.4245(2)0.20149(14)0.29865(9)0.0707(6)
H120.45130.23930.27130.085*
C130.5283(2)0.17171(12)0.33499(8)0.0574(5)
H130.62450.19010.33200.069*
C140.8065(2)0.00189(11)0.45543(7)0.0486(4)
H14A0.86430.05190.45900.058*
H14B0.7491−0.00380.48920.058*
C150.9092(2)−0.07028(10)0.45161(7)0.0476(4)
C160.8816(3)−0.14255(13)0.47997(9)0.0683(6)
H160.7971−0.14740.50140.082*
C170.9788(4)−0.20807(14)0.47689(12)0.0923(9)
H170.9596−0.25660.49630.111*
C181.1030(3)−0.20166(17)0.44535(14)0.0967(10)
H181.1679−0.24590.44330.116*
C191.1315(3)−0.13068(18)0.41706(12)0.0871(8)
H191.2156−0.12620.39540.105*
C201.0357(2)−0.06570(14)0.42059(10)0.0640(5)
H201.0568−0.01710.40150.077*
N10.62952(16)−0.11876(9)0.36013(6)0.0510(4)
N20.80071(16)−0.03192(9)0.31453(6)0.0490(4)
O10.7474(2)−0.15887(10)0.28190(7)0.0880(6)
O20.51534(16)−0.07913(9)0.43836(6)0.0674(4)
O30.85894(15)0.09301(8)0.34929(6)0.0591(4)

Source of material

The title compound was synthesized through two steps. Firstly, 1,3-dimethyl barbituric acid was easily synthesized according to the literature [3], [4]. Secondly, 1,3-methyl barbituric acid (1.56 g, 0.01 mol) was dissolved in approximately 70 mL of acetone, and we added benzyl chloride (1.86 g, 0.01 mol), anhydrous potassium carbonate as dehydrogenation agent and potassium iodide as catalyst. The mixture was heated with stirring to 353 K for 3 h. The product was produced in 50% yield by recrystallization from anhydrous ethanol.

Experimental details

The hydrogen atoms were placed on calculated positions using a riding model (AFIX 33, 43 and 23 options of the SHELX program [2]).

Comment

It is well known that for the treatment of nervous system, barbiturates and its derivatives are widely used in medicine. They may have anti-cancer, anesthesia, sedation, sleep and other medical effects [5], [6], [7], [8], [9], [10] because the characteristic ring of barbituric acid and the base of DNA have certain similarity [11], which also gives a special significance of barbituric acid compounds. In the cyclic system of 1,3-dimethyl barbituric acid, the hydrogen atoms on the 5-position carbon are affected by the electron-withdrawing action of two adjacent carbonyl groups, and are easily lost to form a cyclic conjugate stable carbon anion, which acts as the nucleophilic reagent and the halogenated hydrocarbon carries out alkylation reaction.

All bond lengths and angles are within normal ranges. The typical structural characteristic of the title compound is the C3 atom which acts as a bridge between the 1,3-dimethyl barbituric acid ring and the two benzyl moieties. The dihedral angle between the benzyl rings and the 1,3-dimethyl barbituric acid are 50° and 27°, influenced by steric hindrance. The O2 atom and a H atom from a benzyl ring form a weak hydrogen bonding interaction.

Acknowledgement

We thank the Jilin Province Science and Technology Development Program of China (No. 20140204080GX) for financial support.

References

Bruker: APEX2, SAINT and SADABS. Brucker AXS Inc., Madison, WI, USA (2009).Suche in Google Scholar

Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar

Biltz, H.; Wittek, H.: Über alkylierte und äcylierte Barbitursauren. Chem. Ber. 54 (1921) 1035–1058.10.1002/cber.19210540519Suche in Google Scholar

Cope, A. C.; Heyl, D.; Peck, H. D.; Eide, C.; Arroyo, A.: 1,3-Dimethyl-5-alkyl barbituric Acids. J. Amer. Chem. Soc. 63 (1941) 356–358.10.1021/ja01847a008Suche in Google Scholar

Raffaella, R.; Claudia, P.; Pasquale, P.: Comparison between the effects of pentobarbital or ketamine/nitrous oxide anesthesia on metabolic and endothelial components of coronary reactive hyperemia. Life Sci. 69 (2001) 729–738.10.1016/S0024-3205(01)01161-4Suche in Google Scholar

Habibi, A.; Tarameshloo, Z.: A new and convenient method for synthesis of barbituric acid derivatives. J. Iran. Chem. Soc. 8 (2011) 287–291.10.1007/BF03246226Suche in Google Scholar

Stowe, D. F.; Bosnjak, Z. J.; Kampine, J. P.: Comparison of etomidate, ketamine, midazolam, propofol, and thiopental on function and metabolism of isolated hearts. Anesthesia and Analgesia 74 (1992) 547–558.10.1213/00000539-199204000-00015Suche in Google Scholar PubMed

Lischke, V.; Busse, R.; Hecker, M.: Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br. J. Pharmacol. 115 (1995) 969–974.10.1111/j.1476-5381.1995.tb15905.xSuche in Google Scholar PubMed PubMed Central

Sharpless, S. K.: The pharmacological basis of therapeutics. Macmillan, New York (1965).Suche in Google Scholar

Penthala, N. R.; Ketkar, A.; Sekhar, K. R.; Freeman, M. L.; Eoff, R. L.; Balusu, R.; Crooks, P. A.: 1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: anti-cancer agents that target nucleophosmin 1 (NPM1). Bioorg. Med. Chem 23 (2015) 7226–7233.10.1016/j.bmc.2015.10.019Suche in Google Scholar PubMed PubMed Central

Voet, D.: The crystal and molecular structure of the intermolecular complex 9-ethyladenine-5,S-diethylbarbituric acid. J. Am. Chem. Soc. 94 (1972) 8213–8222.10.1021/ja00778a044Suche in Google Scholar PubMed

Received: 2017-4-19
Accepted: 2017-9-4
Published Online: 2017-9-29
Published in Print: 2017-11-27

©2017 Ya-Nan Wei et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure of potassium 1-methyl-1H-1,2,3,4-tetrazole-5-thiolate, C2H3N4SK
  3. Crystal structure of bis(3-(3-ethylureido)-N,N-dimethylpropan-1-aminium) bis (μ3-2-(hydroxymethyl)-2-(oxidomethyl)propane-1,3-bis(olato))-(μ6-oxo)-hexakis(μ2-oxo)-hexaoxo-hexavanadium(V) – dichloromethane (1/1), C27H60Cl2N6O23V6
  4. Crystal structure of bis(μ3-methanolato-κ3O:O:O)-bis(μ2-methanolato-κ2O:O)-dimethanol-bis{6,6′-(1,3-dihydroxyl-2-acetylpropane-1,3-diyl)bis(2-chloro-4-bromophenolato)}tetramanganese(III) C40H40Br4Cl4Mn4O16
  5. Synthesis and crystal structure of tetrakis(μ2-methanolato)-dimethanol-bis(μ2-2-acetyl-1,3-bis(3,5-dibromo-2-oxidophenyl)propane-1,3-bis(olato)-κ5O1,O2,O3:O3,O4,O5)tetramanganese(III), C40H40Br8Mn4O16
  6. Synthesis and crystal structure tetrakis(μ2-methanolato)-dimethanol-bis(μ2-2-acetyl-1,3-bis(3,5-dichloro-2-oxidophenyl)propane-1,3-bis(olato)-κ5O1,O2,O3:O3,O4,O5), tetramanganese(III), C40H40Cl8Mn4O16
  7. Crystal structure of bis{5-methoxy-2-((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O)}copper(II), C34H34CuN4O6
  8. Crystal structure of (E)-1-(2-hydroxy-3-{[2-hydroxybenzylidene]amino}phenyl)ethan-1-one, C15H13NO3
  9. Crystal structure of bis(μ2-acetato-κ2O:O′)-bis{μ2-4-chloro-2-(8-(4-(diethylamino)-2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenolato-κ6O:O,N,N′,O′′:O′′}tricobalt(II), C44H49Cl2Co3N6O12
  10. Crystal structure of bis{μ2-2,4-dichloro-6-(8-(4-(diethylamino)-2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenolato-κ5O:O,N,N′,O′}dicobalt(II) acetone solvate, C43H48Br4Co2N6O9
  11. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)-bis{μ2-4-chloro-2-(8-(4-(diethylamino)-2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenolato-κ6O:O,N,N′,O′:O′}trizinc(II), C44H49Cl2N6O12Zn3
  12. Crystal structure of bis{5-(N,N′-diethylamine)-5′-methoxy -2,2′-[ethylenediyldioxybis(nitrilomethylidyne)]diphenolato}-bis(μ2-acetato-κ2O:O′)trizinc(II), C46H56Zn3N6O14
  13. Crystal structure of tris(cyano-(hydrogen tris(3,5-dimethylpyrazolyl)borate))-iron(III) 4-methoxypyridinium monohydrate, C24H32BN10O2Fe
  14. Synthesis and crystal structure of bis{1-(((4-(1-(hydroxyimino)ethyl)phenyl)imino)methyl)naphthalen-2-olato-κ2O,N}copper(II), C38H30CuN4O4
  15. Crystal structure of (E)-1-(4-{[(E)-2-Hydroxy-1-naphthalenylmethylene] amino}phenyl)ethanone oxime, C19H16N2O2
  16. The pseudosymmetric crystal structure of 2-(2-naphthalenyl)-3-nitro-2H-1-benzopyran, C38H26N2O6
  17. Crystal structure of 2-benzoyl-3-(4-methoxyphenyl)cyclopropane-1,1-dicarbonitrile, C19H14N2O2
  18. N′-(5-ethoxycarbonyl-3,4-dimethyl-pyrrol-2-yl-methylidene)-4-hydroxybenzohydrazide monohydrate, C17H21N3O5
  19. The crystal structure of carbonyl-[4-(2,4-dichlorophenylamino)pent-3-en-2-onato-κ2N,O]-(triphenylphosphine-κP)rhodium(I), RhC30H25Cl2NO2P
  20. Crystal structure of (E)-5-(diethylamino)-2-(((1,1,2-trihydroxyethyl)iminio)methyl)phenolate, C15H24N2O4
  21. Crystal structure of poly[(μ2-1,4-bis((2-ethyl-1H-benzo[d]imidazol-1-yl)methyl)benzene-κ2N:N′)(μ2-isophthalato-κ4O,O′:O′′,O′′′)cadmium(II)], C34H30N4O4Cd
  22. Crystal structure of 5,6-Dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]chinolizinium 3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate - methanol - water (1/1/1), C36H33NO10
  23. A single crystal study on 2-(methylcarbamoyl)benzoic acid, C9H9NO3
  24. Crystal structure of the salt 1,1′-(ethane-1,2-diyl)bis(1,4-diazabicyclo[2.2.2]octan-1-ium) diperchlorate, C14H28N4(ClO4)2
  25. Crystal structure of 2,5-bis((E)-2-(trifluoromethyl)benzylidene)cyclopentan-1-one, C21H14F6O
  26. Crystal structure of catena-poly[(μ2-benzene-1,4-dicarboxylato-κ2O:O′)-(1-ethyl-6-fluoro-7-(4-methylpiperazin-1-ium-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylato-κ2O,O′)zinc(II)] 1.25 hydrate, C25H26.5N3O8.25FZn
  27. Crystal structure of 1-methyl-1,4-diazabicyclo[2.2.2]octan-1-ium poly[aqua-bis(μ2-perchlorato-κ3O,O′:O′′)sodium], C7H17Cl2N2NaO9
  28. Crystal structure of trimethyammonium 2,6-dicarboxyisonicotinate monohydrate, C11H16N2O7
  29. Crystal structure of dodecaguanidinium bis(tetrapropylammonium) heptacarbonate, C43H128N38O21
  30. Crystal structure of poly[tetraaqua-bis(μ6-benzene-1,2,4,5-tetracarboxylato)nickel(II)diyttrium(III)]dihydrate, C20H16NiO22Y2
  31. Halogen bonds and π–π interactions in the crystal structure of 1,3,5-trifluoro-2,4,6-triiodobenzene–N,N-dimethylformamide (1/1), C9H7F3I3NO
  32. Crystal structure of guanidinium tetraethylammonium carbonate dihydrate, C10H30N4O5
  33. The crystal structure of oxonium chlorido-ethylenediaminetetraactetotin(IV) hydrate, C10H17ClN2O10Sn
  34. Crystal structure of 8-((E)-((4-((E)-1-((benzyloxy)imino)ethyl)phenyl)imino)methyl)-7-hydroxy-4-methyl-2H-chromen-2-one, C26H22N2O4
  35. Crystal structure of bis{5-(diethylamino)-2-(((2-oxo-2H-chromen-6-yl)imino)methyl)phenolato-κ2O,N}copper(II), C40H38CuN4O6
  36. Crystal structure of fac-(acetylacetonato-κ2O,O′)tricarbonyl(tri(p-tolyl)phosphine-κP)rhenium(I), C29H28O5PRe
  37. Crystal structure of fac-(acetylacetonato-κ2O,O′)tricarbonyl(benzyldiphenylphosphine-κP)rhenium(I), C27H24O5PRe
  38. Crystal structure of triethylammonium bis{3-(((3-oxidonaphthalen-1-yl)methylene)amino)-2-oxo-2H-chromen-4-olato-κ3O,N,O′}manganese(III), C46H38MnN3O8
  39. Crystal structure of bis(N,N,N-ethyldimethylethanaminium) bis(heptaselenido-κ2Se1,Se7)palladate(II), C12H32N2PdSe14
  40. Crystal structure of bis(4-(1H-pyrazol-5-yl)pyridine-κ2N:N′)-bis(2-(2-((2,6-difluorophenyl)amino)phenyl)acetate-κO)cadmium(II), C44H34N8CdCl4O4
  41. Crystal structure of 4,4′-(1,4-phenylene)bis(pyridin-1-ium) catena-poly[diaqua-bis(μ2-3′,5′-dicarboxy-[1,1′-biphenyl]-2,5-dicarboxylato-κ2O:O′] dihydrate, C48H42O22N2Ca
  42. The crystal structure of (S)-2-benzylsuccinic acid, C11H12O4
  43. Crystal structure of poly[aqua-(μ3-4-(pyridin-4-yl)isophthalato-κ4O,O′:O′′:O′′′)-(μ2-5-carboxy-2-(pyridin-4-yl)benzoato-κ2O:O′)yttrium(III)], C26H17N2O9Y
  44. Crystal structure of ethyl 1-(3,4-dimethylphenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylate, C14H17N3O2
  45. Crystal structure of tetrakis(methanol-κO)-bis{μ2-3-((4-methoxy-2-oxidobenzylidene)amino)-2-oxo-2H-chromen-4-olate-κ4O,N;O′:O′}dizinc(II), C38H38Zn2N2O14
  46. Crystal structure of bromido(4,4′-dimethoxy-2,2′-bipyridine-κ2N,N′)(isopropyl(diphenyl)phosphane-κP)copper(I), C27H29BrCuN2O2P
  47. Crystal structure of bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)-9,9-dioctylfluorene, C41H64B2O4
  48. Crystal structure of 11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carbaldehyde - a julolidine derivative, C16H15NO3
  49. Crystal structure of 1,3-dimethyl-5,5-dibenzylbarbituric acid, C20H20N2O3
  50. Crystal structure of bis(N,N,N-trimethylethanaminium) poly[bis(μ2-heptaselenido-κ2Se1,Se7)palladate(II)], C10H28N2PdSe14
  51. Crystal structure of 1-{4-[(5-Chloro-2-hydroxy-benzylidene)amino]phenyl} ethanone O-ethyl-oxime, C17H17ClN2O2
  52. The crystal structure of methyl N-(4-bromophenyl)carbamate, C8H8BrNO2
  53. Synthesis and crystal structure of 1-{4-[(2-hydroxy-benzylidene)amino]phenyl}ethanone oxime, C15H14N2O2
  54. Crystal structure of 1,1′-butanebis(3-methyl-1H-imidazol-3-ium)bis(hexafluorophosphate), C12H20F12N4P2
  55. (E)-N-benzylidene-3-(benzylthio)-5-p-tolyl-4H-1,2,4-triazol-4-amine, C23H20N4S
  56. Crystal structure of ethyl 5-methyl-1-(pyridin-3-yl)-1H-1,2,3-triazole-4-carboxylate, C11H12N4O2
  57. Crystal structure of 5,5-difluoro-10-(4-fluorophenyl)-1,3,7,9-tetramethyl-5H-4l4,5l4-dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine - a Z′ = 3 structure, C19H18B2F3N2
  58. The crystal structure of the Matrine derivative: 12-(1H-indol-1-yl)dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one hydrate, C23H29N3O
  59. The crystal structure of tris(μ2-1,3-bis(4,4,4-trifluoro-3-oxido-1-(oxo)but-2-en-1-yl)phenyl-κ4O,O′:O′′,O′′′)-bis(1,2-dimethoxyethane-κ2O,O′)dilutetium(III), C50H38F18Lu2O16
  60. The crystal structure of (Z)-2-(3-(2-(4-chlorobenzoyl)hydrazono)-2-oxoindolin-1-yl) acetic acid, C17H12ClN3O4
  61. Synthesis and crystal structure of trans-tetraqua-bis(2-(((7-hydroxy-3-(4-hydroxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)ammonio)acetato-κO)cobalt(II) hexahydrate, C36H48CoN2O28S2
  62. The crystal structure of N,N-dimethyl-2,6-di-p-tolylpyrimidin-4-amine, C20H21N3
  63. The crystal structure (E)-4-methyl-N′-(2-nitrobenzylidene)benzenesulfonohydrazide, C14H13N3O4S
  64. Crystal structure of catena-poly[(μ2-1,3-bis(benzimidazol-1-yl)propane κ2N:N′)-(μ2-5-methoxyisophthalato-κ2O:O′)zinc(II)] hydrate, C26H24ZnN4O6
  65. The crystal structure of (E)-N′-(quinolin-2-ylmethylene)furan-2-carbohydrazide monohydrate, C15H13N3O3
  66. Crystal structure of 2,8-diphenyl-3,7,9-trioxa-1-azaspiro[4.5]dec-1-ene, C18H17N1O3
  67. Crystal structure of diethyl 2-(4-chlorophenyl)-1,3-dioxane-5,5-dicarboxylate, C16H19ClO6
  68. Crystal structure of 1-(carboxymethyl)-1H-benzo[d][1,2,3]triazole 3-oxide, C8H7N3O3
  69. Crystal structure of (acetylacetonato-κ2O,O′)-(2-amino-6-chlorobenzoato-κO)-oxido(1,10-phenanthroline-κ2N,N′)vanadium(IV) – trichloromethane (1/1)
  70. Crystal structure of (1E,4E)-1,5-bis(4-chlorophenyl)penta-1,4-dien-3-one, C17H12Cl2O
  71. The crystal structure of trans-dibromido-bis(pyridine-κN)platinum(II), C10H10Br2N2Pt
Heruntergeladen am 25.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2017-0124/html
Button zum nach oben scrollen